<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34680939</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>A Novel Variant in Superoxide Dismutase 1 Gene (<i>p.V119M</i>) in Als Patients with Pure Lower Motor Neuron Presentation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1544</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes12101544</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive and fatal disorder characterized by degeneration of motor neurons in the cerebral cortex, brain stem, and spinal cord. Most cases of ALS appear sporadically, but 5-10% of patients have a family history of disease. Mutations in the superoxide dismutase 1 gene (<i>SOD1</i>) have been found in 12-23% of familial cases and in 1-2% of sporadic cases. Currently, more than 180 different <i>SOD1</i> gene variants have been identified in ALS patients. Here, we describe two apparently sporadic ALS patients carrying the same <i>SOD1</i> c.355G&gt;A variant, leading to the <i>p.V119M</i> substitution, not previously described. Both the patients showed pure lower motor neuron phenotype. The former presented with the flail leg syndrome, a rare ALS variant, characterized by progressive distal onset weakness and atrophy of lower limbs, slow progression and better survival than typical ALS. The latter exhibited rapidly progressive weakness of upper and lower limbs, neither upper motor neuron nor bulbar involvement, and shorter survival than typical ALS. We provide an accurate description of the phenotype, and a bioinformatics analysis of the <i>p.V119M</i> variant on protein structure. This study may increase the knowledge about genotype-phenotype correlations in ALS and improve the approach to ALS patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ricci</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2431-0308</Identifier><AffiliationInfo><Affiliation>Department of Medical, Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannini</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical, Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riolo</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical, Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bocci</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2384-5909</Identifier><AffiliationInfo><Affiliation>Department of Medical, Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casali</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical, Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battistini</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2887-7624</Identifier><AffiliationInfo><Affiliation>Department of Medical, Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="Y">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SOD1 gene</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">flail leg variant</Keyword><Keyword MajorTopicYN="N">modelization</Keyword><Keyword MajorTopicYN="N">novel variant</Keyword><Keyword MajorTopicYN="N">p.V119M</Keyword><Keyword MajorTopicYN="N">phenotype-genotype correlation</Keyword><Keyword MajorTopicYN="N">progressive muscular atrophy</Keyword><Keyword MajorTopicYN="N">pure lower motor neuron phenotype</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34680939</ArticleId><ArticleId IdType="pmc">PMC8535540</ArticleId><ArticleId IdType="doi">10.3390/genes12101544</ArticleId><ArticleId IdType="pii">genes12101544</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gordon P.H. Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials. Aging Dis. 2013;4:295&#x2013;310. doi: 10.14336/AD.2013.0400295.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2013.0400295</ArticleId><ArticleId IdType="pmc">PMC3794725</ArticleId><ArticleId IdType="pubmed">24124634</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland L.P., Shneider N. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Tard C., Defebvre L., Moreau C., Devos D., Danel-Brunaud V. Clinical features of amyotrophic lateral sclerosis and their prognostic value. Rev. Neurol. 2017;173:263&#x2013;272. doi: 10.1016/j.neurol.2017.03.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2017.03.029</ArticleId><ArticleId IdType="pubmed">28477850</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera L.C., Leigh P.N. Amyotrophic lateral sclerosis. Orphanet J. Rare Dis. 2009;4:1&#x2013;22. doi: 10.1186/1750-1172-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Moglia C., Canosa A., Manera U., Vasta R., Brunetti M., Barberis M., Corrado L., D&#x2019;Alfonso S., Bersano E., et al. Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology. 2019;93:e984&#x2013;e994. doi: 10.1212/WNL.0000000000008063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008063</ArticleId><ArticleId IdType="pmc">PMC6745732</ArticleId><ArticleId IdType="pubmed">31409738</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe4;umer D., Talbot K., Turner M.R. Advances in motor neurone disease. J. R. Soc. Med. 2014;107:14&#x2013;21. doi: 10.1177/0141076813511451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0141076813511451</ArticleId><ArticleId IdType="pmc">PMC3883149</ArticleId><ArticleId IdType="pubmed">24399773</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M., Eisen A., Hardiman O., Burrell J., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Calvo A., Moglia C., Mazzini L., Mora G., PARALS Study Group Phenotypic heterogeneity of amyotrophic lateral sclerosis: A population based study. J. Neurol. Neurosurg. Psychiatry. 2011;82:740&#x2013;746. doi: 10.1136/jnnp.2010.235952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J., Appel S., Baloh R.H., Barohn R., Brooks B.R., Elman L., Floeter M.K., Henderson C., Lomen-Hoerth C., Macklis J.D., et al. Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotroph. Lateral Scler. Front. Degener. 2013;14:5&#x2013;18. doi: 10.3109/21678421.2013.778548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.778548</ArticleId><ArticleId IdType="pmc">PMC3779649</ArticleId><ArticleId IdType="pubmed">23678876</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera L.C., Mathers S., Talman P., Galtrey C., Parkinson M.H., Ganesalingam J., Willey E., Ampong M.A., Ellis C.M., Shaw C.E., et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology. 2009;72:1087&#x2013;1094. doi: 10.1212/01.wnl.0000345041.83406.a2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000345041.83406.a2</ArticleId><ArticleId IdType="pmc">PMC2821838</ArticleId><ArticleId IdType="pubmed">19307543</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg N., Park S.B., Vucic S., Yiannikas C., Spies J., Howells J., Huynh W., Matamala J.M., Krishnan A., Pollard J.D., et al. Differentiating lower motor neuron syndromes. J. Neurol. Neurosurg. Psychiatry. 2016;88:474&#x2013;483. doi: 10.1136/jnnp-2016-313526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-313526</ArticleId><ArticleId IdType="pmc">PMC5529975</ArticleId><ArticleId IdType="pubmed">28003344</ArticleId></ArticleIdList></Reference><Reference><Citation>Norris F.H. Adult Progressive Muscular Atrophy and Hereditary Spinal Muscular Atrophies. In: Vinken P.J., Bruyn G.W., Klawans H.L., De Jong J.M.B.V., editors. Handbook of Clinical Neurolo-gy: Diseases of the Motor System. Volume 59. Elsevier; San Diego, CA, USA: 1991. pp. 13&#x2013;34.</Citation></Reference><Reference><Citation>De Carvalho M., Scotto M., Swash M. Clinical patterns in progressive muscular atrophy (PMA): A prospective study. Amyotroph. Lateral Scler. 2007;8:296&#x2013;299. doi: 10.1080/17482960701452902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701452902</ArticleId><ArticleId IdType="pubmed">17852011</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M., Heverin M., Doherty M.A., Davis N., Corr E.M., Vajda A., Pender N., McLaughlin R., Hardiman O. Determining the incidence of familiality in ALS. Neurol. Genet. 2018;4:e239. doi: 10.1212/NXG.0000000000000239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000239</ArticleId><ArticleId IdType="pmc">PMC5961194</ArticleId><ArticleId IdType="pubmed">29845113</ArticleId></ArticleIdList></Reference><Reference><Citation>Volk A.E., Weishaupt J.H., Andersen P.M., Ludolph A.C., Kubisch C. Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis. Med. Genet. 2018;30:252&#x2013;258. doi: 10.1007/s11825-018-0185-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11825-018-0185-3</ArticleId><ArticleId IdType="pmc">PMC6132774</ArticleId><ArticleId IdType="pubmed">30220791</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z.-Y., Zhou Z.-R., Che C.-H., Liu C.-Y., He R.-L., Huang H.-P. Genetic epidemiology of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L., Pitout I.L., Fletcher S., Wilton S., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;364:362. doi: 10.1038/364362c0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/364362c0</ArticleId><ArticleId IdType="pubmed">8332197</ArticleId></ArticleIdList></Reference><Reference><Citation>Okado-Matsumoto A., Fridovich I. Subcellular Distribution of Superoxide Dismutases (SOD) in Rat Liver. J. Biol. Chem. 2001;276:38388&#x2013;38393. doi: 10.1074/jbc.M105395200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M105395200</ArticleId><ArticleId IdType="pubmed">11507097</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardo C.A., Xu Z., Borchelt D.R., Price D.L., Sisodia S.S., Cleveland D. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc. Natl. Acad. Sci. USA. 1995;92:954&#x2013;958. doi: 10.1073/pnas.92.4.954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.4.954</ArticleId><ArticleId IdType="pmc">PMC42615</ArticleId><ArticleId IdType="pubmed">7862672</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M., Pu H., Chiu A., Canto M.D., Polchow C., Alexander D., Caliendo J., Hentati A., Kwon Y., Deng H., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L., Becher M., Lee M., Anderson K., Jenkins N., Copeland N., Sisodia S., Rothstein J., Borchelt D., Price D., et al. ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions. Neuron. 1997;18:327&#x2013;338. doi: 10.1016/S0896-6273(00)80272-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80272-X</ArticleId><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Reaume A.G., Elliott J.L., Hoffman E.K., Kowall N.W., Ferrante R.J., Siwek D.R., Wilcox H.M., Flood D.G., Beal M.F., Jr., Scott R.W., et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 1996;13:43&#x2013;47. doi: 10.1038/ng0596-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0596-43</ArticleId><ArticleId IdType="pubmed">8673102</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel O., Powell J.F., Andersen P.M., Al-Chalabi A. ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum. Mutat. 2012;33:1345&#x2013;1351. doi: 10.1002/humu.22157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22157</ArticleId><ArticleId IdType="pubmed">22753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly O., Le Gall L., McCluskey G., Donaghy C.G., Duddy W.J., Duguez S. A Systematic Review of Genotype&#x2013;Phenotype Correlation across Cohorts Having Causal Mutations of Different Genes in ALS. J. Pers. Med. 2020;10:58. doi: 10.3390/jpm10030058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm10030058</ArticleId><ArticleId IdType="pmc">PMC7564886</ArticleId><ArticleId IdType="pubmed">32610599</ArticleId></ArticleIdList></Reference><Reference><Citation>Bali T., Self W., Liu J., Siddique T., Wang L.H., Bird T.D., Ratti E., Atassi N., Boylan K.B., Glass J.D., et al. Defining SOD1 ALS natural history to guide therapeutic clinical trial design. J. Neurol. Neurosurg. Psychiatry. 2016;88:99&#x2013;105. doi: 10.1136/jnnp-2016-313521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-313521</ArticleId><ArticleId IdType="pmc">PMC5136332</ArticleId><ArticleId IdType="pubmed">27261500</ArticleId></ArticleIdList></Reference><Reference><Citation>Wurster C.D., Ludolph A.C. Antisense oligonucleotides in neurological disorders. Ther. Adv. Neurol. Disord. 2018;11:11. doi: 10.1177/1756286418776932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756286418776932</ArticleId><ArticleId IdType="pmc">PMC5971383</ArticleId><ArticleId IdType="pubmed">29854003</ArticleId></ArticleIdList></Reference><Reference><Citation>Amado D.A., Davidson B.L. Gene therapy for ALS: A review. Mol. Ther. 2021 doi: 10.1016/j.ymthe.2021.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2021.04.008</ArticleId><ArticleId IdType="pmc">PMC8636154</ArticleId><ArticleId IdType="pubmed">33839324</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T.M., Pestronk A., David W., Rothstein J., Simpson E., Appel S.H., Andres P.L., Mahoney K., Allred P., Alexander K., et al. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: A phase 1, randomised, first-in-man study. Lancet Neurol. 2013;12:435&#x2013;442. doi: 10.1016/S1474-4422(13)70061-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70061-9</ArticleId><ArticleId IdType="pmc">PMC3712285</ArticleId><ArticleId IdType="pubmed">23541756</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T., Cudkowicz M., Shaw P., Andersen P.M., Atassi N., Bucelli R.C., Genge A., Glass J., Ladha S., Ludolph A.L., et al. Phase 1&#x2013;2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. N. Engl. J. Med. 2020;383:109&#x2013;119. doi: 10.1056/NEJMoa2003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2003715</ArticleId><ArticleId IdType="pubmed">32640130</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Waterhouse A., Bertoni M., Bienert S., Studer G., Tauriello G., Gumienny R., Heer F.T., Beer T.A.P.D., Rempfer C., Bordoli L., et al. SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46:W296&#x2013;W303. doi: 10.1093/nar/gky427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky427</ArticleId><ArticleId IdType="pmc">PMC6030848</ArticleId><ArticleId IdType="pubmed">29788355</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F., Fujimura C., Ishida S., Nakajima H., Furutama D., Uehara H., Shinoda K., Sugino M., Hanafusa T. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66:265&#x2013;267. doi: 10.1212/01.wnl.0000194316.91908.8a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000194316.91908.8a</ArticleId><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Battistini S., Ricci C., Giannini F., Calzavara S., Greco G., Del Corona A., Mancuso M., Battistini N., Siciliano G., Carrera P. G41SSOD1mutation: A common ancestor for six ALS Italian families with an aggressive phenotype. Amyotroph. Lateral Scler. 2010;11:210&#x2013;215. doi: 10.3109/17482960902995592.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902995592</ArticleId><ArticleId IdType="pubmed">19488901</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz M.E., McKenna-Yasek D., Sapp P.E., Chin W., Geller B., Hayden D.L., Schoenfeld D.A., Hosler B.A., Horvitz H.R., Brown R.H. Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis. Ann. Neurol. 1997;41:210&#x2013;221. doi: 10.1002/ana.410410212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410410212</ArticleId><ArticleId IdType="pubmed">9029070</ArticleId></ArticleIdList></Reference><Reference><Citation>Rainero I., Pinessi L., Tsuda T., Vignocchi M.G., Vaula G., Calvi L., Cerrato P., Rossi B., Bergamini L., McLachlan D.R.C., et al. SOD1 missense mutation in an Italian family with ALS. Neurology. 1994;44:347&#x2013;349. doi: 10.1212/WNL.44.2.347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.44.2.347</ArticleId><ArticleId IdType="pubmed">8309590</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Traynor B.J., Lombardo F., Fimognari M., Calvo A., Ghiglione P., Mutani R., Restagno G. Prevalence of SOD1 mutations in the Italian ALS population. Neurology. 2008;70:533&#x2013;537. doi: 10.1212/01.wnl.0000299187.90432.3f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000299187.90432.3f</ArticleId><ArticleId IdType="pubmed">18268245</ArticleId></ArticleIdList></Reference><Reference><Citation>Berdy&#x144;ski M., Ku&#x17a;ma-Kozakiewicz M., Ricci C., Kubiszewska J., Millecamps S., Salachas F., &#x141;usakowska A., Carrera P., Meininger V., Battistini S., et al. Recurrent G41S mutation in Cu/Zn superoxide dismutase gene (SOD1) causing familial amyotrophic lateral sclerosis in a large Polish family. Amyotroph. Lateral Scler. 2011;13:132&#x2013;136. doi: 10.3109/17482968.2011.600316.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.600316</ArticleId><ArticleId IdType="pubmed">21877919</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksoy H., Deng H., Juneja T., Storey E., Gardner R.M., Jacob R.L., Siddique T., Dean G., Elian M., Deng G., et al. A4T Mutation in the SOD1 Gene Causing Familial Amyotrophic Lateral Sclerosis. Neuroepidemiology. 2003;22:235&#x2013;238. doi: 10.1159/000070564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000070564</ArticleId><ArticleId IdType="pubmed">12792143</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xe9;gal L., Vanopdenbosch L., Tilkin P., Bosch L.V.D., Thijs V., Sciot R., Robberecht W. The G93C Mutation in Superoxide Dismutase 1. Arch. Neurol. 2006;63:262&#x2013;267. doi: 10.1001/archneur.63.2.262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.63.2.262</ArticleId><ArticleId IdType="pubmed">16476815</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Moglia C., Canosa A., Manera U., D&#x2019;Ovidio F., Vasta R., Grassano M., Brunetti M., Barberis M., Corrado L., et al. ALS phenotype is influenced by age, sex, and genetics. Neurology. 2020;94:e802&#x2013;e810. doi: 10.1212/WNL.0000000000008869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008869</ArticleId><ArticleId IdType="pubmed">31907290</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim W.-K., Liu X., Sandner J., Pasmantier M., Andrews J., Rowland L.P., Mitsumoto H. Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology. 2009;73:1686&#x2013;1692. doi: 10.1212/WNL.0b013e3181c1dea3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181c1dea3</ArticleId><ArticleId IdType="pmc">PMC2788803</ArticleId><ArticleId IdType="pubmed">19917992</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Sims K.B., Xin W.W., Kiely R., O&#x2019;Neill G., Ravits J., Pioro E., Harati Y., Brower R.D., Levine J.S., et al. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: A decade of discoveries, defects and disputes. Amyotroph. Lateral Scler. 2003;4:62&#x2013;73. doi: 10.1080/14660820310011700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820310011700</ArticleId><ArticleId IdType="pubmed">14506936</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T., Kawata A., Kato S., Hayashi M., Takamoto K., Hirai S., Yamaguchi S., Komori T., Oda M. Autonomic failure in ALS with a novel SOD1 gene mutation. Neurology. 2000;54:1534&#x2013;1537. doi: 10.1212/WNL.54.7.1534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.54.7.1534</ArticleId><ArticleId IdType="pubmed">10751275</ArticleId></ArticleIdList></Reference><Reference><Citation>Brotherton T., Polak M., Kelly C., Birve A., Andersen P., Marklund S.L., Glass J.D. A novel ALS SOD1 C6S mutation with implications for aggregation related toxicity and genetic counseling. Amyotroph. Lateral Scler. 2010;12:215&#x2013;219. doi: 10.3109/17482968.2010.531279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.531279</ArticleId><ArticleId IdType="pubmed">21073275</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohno S., Takahashi Y., Miyajima H., Serizawa M., Mizoguchi K. A novel mutation (Cys6Gly) in the Cu/Zn superoxide dismutase gene associated with rapidly progressive familial amyotrophic lateral sclerosis. Neurosci. Lett. 1999;276:135&#x2013;137. doi: 10.1016/S0304-3940(99)00803-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(99)00803-4</ArticleId><ArticleId IdType="pubmed">10624810</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita M., Aoki M., Abe K., Hasegawa T., Sakuma R., Onodera Y., Ichikawa N., Nishizawa M., Itoyama Y. A novel two-base mutation in the CuZn superoxide dismutase gene associated with familial amyotrophic lateral sclerosis in Japan. Neurosci. Lett. 1996;205:79&#x2013;82. doi: 10.1016/0304-3940(96)12378-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(96)12378-8</ArticleId><ArticleId IdType="pubmed">8907321</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindberg M.J., Bystr&#xf6;m R., Bokn&#xe4;s N., Andersen P.M., Oliveberg M. Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants. Proc. Natl. Acad. Sci. USA. 2005;102:9754&#x2013;9759. doi: 10.1073/pnas.0501957102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0501957102</ArticleId><ArticleId IdType="pmc">PMC1174986</ArticleId><ArticleId IdType="pubmed">15987780</ArticleId></ArticleIdList></Reference><Reference><Citation>Seetharaman S.V., Prudencio M., Karch C., Holloway S.P., Borchelt D.R., Hart P.J. Immature Copper-Zinc Superoxide Dismutase and Familial Amyotrophic Lateral Sclerosis. Exp. Biol. Med. 2009;234:1140&#x2013;1154. doi: 10.3181/0903-MR-104.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/0903-MR-104</ArticleId><ArticleId IdType="pmc">PMC2850267</ArticleId><ArticleId IdType="pubmed">19596823</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller A.-F. Superoxide dismutases: Active sites that save, but a protein that kills. Curr. Opin. Chem. Biol. 2004;8:162&#x2013;168. doi: 10.1016/j.cbpa.2004.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbpa.2004.02.011</ArticleId><ArticleId IdType="pubmed">15062777</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>